Cintia Piccina

Companies

• Autolus TherapeuticsU.S. CCO & Country Gen Manager Mar 18, 2026 to now¹
• Adaptimmune (United Kingdom)Chief Commercial Officer Jan 31, 2022 to now²
• Kalaris Therapeutics, Inc.Chief Commercial Officer Jun 21, 2023 to Jul 5, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKalaris Therapeutics, Inc. KLRS147,000 shares⁴$280.8K at $1.91Jul 3, 2023
• ATAutolus Therapeutics AUTL13,287 shares⁵$20.9K at $1.57Sep 2, 2026
• AUAdaptimmune (United Kingdom) ADAPY18,421 shares⁶$433 at $0.02Jan 15, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 2, 2026Sold 6,713 shares at $2.34 of Autolus Therapeutics⁵
• Sep 1, 2026Exercised options 20,000 shares at $2.35 of Autolus Therapeutics⁵
• Jan 15, 2025Sold 12,991 shares at $0.57 of Adaptimmune (United Kingdom)⁶
• Jun 18, 2024Sold 24,531 shares at $0.93 of Adaptimmune (United Kingdom)⁷
• Jul 3, 2023Granted 147,000 shares of Kalaris Therapeutics, Inc.⁴
• Jan 31, 2023Sold 11,890 shares at $1.87 of Adaptimmune (United Kingdom)⁸
• Aug 1, 2022Sold 21,040 shares at $1.77 of Adaptimmune (United Kingdom)⁹